Lourdes Felix - BioCorRx CFO, Treasurer and Director
| BICXDelisted Stock | USD 1.76 0.00 0.00% |
Director
Ms. Lourdes Felix is Chief Financial Officer, Chief Operating Officer, Treasurer, Director of BioCorRx Inc. Ms. Felix is a corporate finance executive offering over fifteen years of combined experience in public accounting and in the private sector in building, leading, and advising corporations through complex restructurings. Ms. Felix was instrumental in assisting in capital procurement and implementing an audit committee. Ms. Felix is thoroughly experienced in guiding troubled companies to greater efficiency and profitability. Ms. Felix has acquired expertise in securities laws and knowledge of SOX requirements. Ms. Felix has worked with private and public SEC reporting companies. Ms. Felix was previously the controller for a midsize public accounting firm for over seven years and was responsible for the operations and financial management of regional offices. Her experience includes a wide variety of industries including advertising, marketing, nonprofit organizations, medical practices, mortgage banking, manufacturing and SEC reporting companies. Ms. Felix has assisted companies with documented contributions leading to improved financial performance, heightened productivity, and enhanced internal controls. Ms. Felix is very active in the Hispanic community and speaks fluent Spanish since 2016.
| Age | 55 |
| Tenure | 8 years |
| Phone | 714 462 4880 |
| Web | https://www.biocorrx.com |
BioCorRx Management Efficiency
The company has return on total asset (ROA) of (2.5187) % which means that it has lost $2.5187 on every $100 spent on assets. This is way below average. BioCorRx's management efficiency ratios could be used to measure how well BioCorRx manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 174.16 K in liabilities with Debt to Equity (D/E) ratio of 5.72, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BioCorRx has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist BioCorRx until it has trouble settling it off, either with new capital or with free cash flow. So, BioCorRx's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioCorRx sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioCorRx to invest in growth at high rates of return. When we think about BioCorRx's use of debt, we should always consider it together with cash and equity.
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. Biocorrx operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. BioCorRx [BICX] is traded as part of a regulated electronic over-the-counter service offered by the NASD. Management Performance
| Return On Asset | -2.52 |
BioCorRx Leadership Team
Elected by the shareholders, the BioCorRx's board of directors comprises two types of representatives: BioCorRx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioCorRx. The board's role is to monitor BioCorRx's management team and ensure that shareholders' interests are well served. BioCorRx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioCorRx's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brady Granier, Interim CEO, COO, Secretary and Director | ||
| Lourdes Felix, CFO, Treasurer and Director | ||
| Thomas Welch, Ex VP | ||
| George Fallieras, Medical Consultant |
BioCorRx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is BioCorRx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -2.52 | |||
| Operating Margin | (33.51) % | |||
| Current Valuation | 13.9 M | |||
| Shares Outstanding | 7.63 M | |||
| Shares Owned By Insiders | 58.67 % | |||
| Price To Earning | 3.61 X | |||
| Price To Book | 209.37 X | |||
| Price To Sales | 42.21 X | |||
| Revenue | 48.27 K | |||
| Gross Profit | 42.39 K |
Pair Trading with BioCorRx
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioCorRx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCorRx will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to BioCorRx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioCorRx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioCorRx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioCorRx to buy it.
The correlation of BioCorRx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioCorRx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioCorRx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioCorRx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the BioCorRx information on this page should be used as a complementary analysis to other BioCorRx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in BioCorRx OTC Stock
If you are still planning to invest in BioCorRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioCorRx's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |